<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1981-1072'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/profile/">Profile</a>
<span>Flowcytometry Panel - Lymphoproliferative Disorder Characterization</span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">Flowcytometry Panel - Lymphoproliferative Disorder Characterization (Case based antibodies selected from the list given below CD45, CD34, HLA-DR, CD38, TdT, CD19, CD20, CD22, CD10, CD79a, kappa, lambda, CD23, CD11c, CD25, CD103, CD3, CD1a, CD2, CD4, CD5, CD8, CD7, CD16, CD56, CD57, CD123, CD200,bcl2, FMC-7, ZAP-70 )</h1>
<div class="post-text">
<p>Lymphoproliferative disorders (LPDs) are a heterogeneous group of diseases characterized by the excessive production of lymphocytes, a type of white blood cell. LPDs encompass various conditions, including lymphomas, chronic lymphocytic leukemia, and multiple myeloma, among others. The Flow Cytometry Panel for Lymphoproliferative Disorder Characterization is a crucial tool in diagnosing, staging, and monitoring these conditions.</p>
<p>Flow cytometry is an advanced technology that uses lasers to evaluate and sort cells based on their physical and chemical properties. In the context of LPDs, this panel identifies and quantifies specific protein markers on the surface of lymphocytes, assisting in determining the subtype of LPD and informing the optimal therapeutic approach.</p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Profile Name</th>
			<td scope="col">Flowcytometry Panel - Lymphoproliferative Disorder Characterization (Case based antibodies selected from the list given below CD45, CD34, HLA-DR, CD38, TdT, CD19, CD20, CD22, CD10, CD79a, kappa, lambda, CD23, CD11c, CD25, CD103, CD3, CD1a, CD2, CD4, CD5, CD8, CD7, CD16, CD56, CD57, CD123, CD200,bcl2, FMC-7, ZAP-70 )</td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Blood/Bone Marrow</td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>There are no specific requirements for fasting, hydration, or other specific preparations before this test. However, make sure to inform your doctor about any ongoing medications, allergies, or health conditions you might have.</td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>24 hours</td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>â‚¹ 13000</td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
<h2 class="test-h2 mt-3">What is the Flow Cytometry Panel for Lymphoproliferative Disorder Characterization? </h2>
<p>This panel is a comprehensive diagnostic tool used to identify and quantify specific markers on lymphocytes. It aids in the detection and classification of lymphoproliferative disorders.</p>

<h2 class="test-h2 mt-3">What preparation is needed for this test?</h2>
<p> No specific preparation is required for this test. However, always inform your doctor about your ongoing medications and overall health condition before any laboratory investigation.</p>

<!--section achieved-->
<?php include "../../include/iconsbox.php" ?>
<!--//section achieved-->

<h2 class="test-h2 mt-3">What does the panel measure? </h2>
<p>This panel measures specific protein markers on lymphocytes. The presence and quantity of these markers help differentiate between various types of lymphoproliferative disorders and guide treatment planning.</p>

<h2 class="test-h2 mt-3">How frequently should I undergo this test?</h2>
<p> The frequency of this test depends on your doctor's discretion, considering your diagnosis, treatment response, and risk of disease recurrence.</p>

<h2 class="test-h2 mt-3">What do normal results look like?</h2>
<p> Normal results can vary as the panel measures multiple cellular markers. Your doctor will interpret the results in the context of your overall health, symptoms, and other diagnostic test results.</p>

<h2 class="test-h2 mt-3">Are there precautions to take before the test?</h2>
<p> There are no specific precautions to take before the test. However, ensure to inform your doctor about any medications or supplements you are taking.</p>

<h2 class="test-h2 mt-3">What factors could affect the test results? </h2>
<p>Factors affecting the test results could include certain medications, underlying health conditions, or the sample collection method. Some of these factors are modifiable, such as adjusting medication use, while others are not, like inherent genetic factors.</p>

<h2 class="test-h2 mt-3">Whom should I consult if my test results are abnormal? </h2>
<p>If your test results are abnormal, consult a hematologist or oncologist. They can interpret the results in light of your health status and guide you on the next steps.</p>

<h2 class="test-h2 mt-3">Are there any risks associated with this test? </h2>
<p>The test may involve a blood draw or bone marrow aspiration, which carry a small risk of bleeding, infection, or discomfort at the puncture site. However, serious complications are rare.</p>

<h2 class="test-h2 mt-3">Does an abnormal result imply I have a lymphoproliferative disorder?</h2>
<p> An abnormal result could be indicative of a lymphoproliferative disorder, but it doesn't confirm the diagnosis. The results should be interpreted in conjunction with your clinical symptoms, medical history, and other diagnostic tests.</p>

<h2 class="test-h2 mt-3">What are the treatment options if I'm diagnosed with a lymphoproliferative disorder? </h2>
<p>Treatment options for LPDs are personalized based on the subtype of disorder, disease stage, and individual health. Common treatment modalities include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and stem cell transplant.</p>

<h2 class="test-h2 mt-3">Can I prevent lymphoproliferative disorders?</h2>
<p> While there's no guaranteed way to prevent LPDs, maintaining a healthy lifestyle can reduce the overall risk of developing cancer. Regular exercise, a balanced diet, and avoiding tobacco and excessive alcohol are generally recommended.</p>

<h2 class="test-h2 mt-3">Can lifestyle changes affect the outcomes of lymphoproliferative disorders?</h2>
<p> Adopting a healthy lifestyle can support overall health, strengthen the immune system, and improve your body's response to treatment for lymphoproliferative disorders.</p>

<h2 class="test-h2 mt-3">Can this test be done during pregnancy?</h2>
<p> Consult your doctor regarding the necessity and timing of this test during pregnancy. Some aspects of the test might need to be postponed until after delivery, if possible.</p>

<h2 class="test-h2 mt-3">Does this test involve radiation exposure? </h2>
<p>No, flow cytometry does not involve radiation exposure. It uses lasers and electronic sensors to measure cell properties.</p>

<p>Understanding the nature of lymphoproliferative disorders is a challenging task given their complexity and heterogeneity. However, the Flow Cytometry Panel for Lymphoproliferative Disorder Characterization offers a crucial roadmap to navigate the diagnostic and therapeutic journey, fostering hope for those battling these conditions.</p>

</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>